D

Dechra Pharmaceuticals PLC
F:1PK

Watchlist Manager
Dechra Pharmaceuticals PLC
F:1PK
Watchlist
Price: 45.2 EUR Market Closed
Market Cap: €5.1B

Profitability Summary

Dechra Pharmaceuticals PLC's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Dechra Pharmaceuticals PLC

Margins Comparison
Dechra Pharmaceuticals PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
Loading...
Loading...
US
Zoetis Inc
NYSE:ZTS
54.1B USD
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
44.7B EUR
Loading...
Loading...
Loading...
US
Elanco Animal Health Inc
NYSE:ELAN
12.1B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Dechra Pharmaceuticals PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Zoetis Inc
NYSE:ZTS
54.1B USD
Loading...
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
44.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Elanco Animal Health Inc
NYSE:ELAN
12.1B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Dechra Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate